• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S1P1 与 VEGFR-2 与细胞外调节激酶 1/2 和蛋白激酶 C-α形成信号复合物,调节 ML-1 甲状腺癌细胞迁移。

S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration.

机构信息

Department of Biosciences, Abo Akademi University, BioCity, Tykistökatu 6, 20520 Turku, Finland.

出版信息

Endocrinology. 2010 Jul;151(7):2994-3005. doi: 10.1210/en.2009-1387. Epub 2010 May 25.

DOI:10.1210/en.2009-1387
PMID:20501673
Abstract

Sphingosine 1-phosphate (S1P) and vascular endothelial growth factor receptor 2 (VEGFR-2) signaling have been shown to integrate in many biological processes. The follicular thyroid carcinoma cell line ML-1 expresses VEGFR-2 and secretes substantial amounts of both vascular endothelial growth factor (VEGF)-A and VEGF-C. ML-1 cells also express S1P-receptors (S1P(1-3,5)). S1P is able to phosphorylate VEGFR-2, and inhibiting VEGFR-2 attenuates S1P-induced migration and down-regulates S1P(1) expression in ML-1 cells. In the present study, we focused on the interactions between S1P(1) and VEGFR-2. We show that S1P receptors form complexes with VEGFR-2 and that the S1P(1)/VEGFR-2 complex associates with protein kinase C (PKC)-alpha and ERK1/2. Furthermore, the complex evokes bidirectional signaling since the S1P-induced ERK1/2 phosphorylation is sensitive to VEGFR-2 kinase inhibition and VEGF-A-induced ERK1/2 phosphorylation is sensitive to pertussis toxin treatment as well as S1P(1) small interfering RNA (siRNA) treatment. Both S1P- and VEGF-A-induced haptotaxis is sensitive to pertussis toxin treatment and S1P(1) siRNA treatment. Phosphorylation of ERK1/2 evoked by both VEGF-A and the S1P(1) agonist SEW-2871 is inhibited by PKC-alpha and PKC-betaI siRNA. We hypothesize that VEGFR-2 forms a signaling complex with S1P(1), evoking bidirectional signaling regulating both ERK1/2 phosphorylation and haptotaxis of ML-1 cells.

摘要

鞘氨醇 1-磷酸(S1P)和血管内皮生长因子受体 2(VEGFR-2)信号已被证明在许多生物学过程中整合在一起。滤泡甲状腺癌细胞系 ML-1 表达 VEGFR-2 并分泌大量血管内皮生长因子(VEGF)-A 和 VEGF-C。ML-1 细胞还表达 S1P 受体(S1P(1-3,5))。S1P 能够磷酸化 VEGFR-2,并且抑制 VEGFR-2 可减弱 S1P 诱导的迁移,并下调 ML-1 细胞中的 S1P(1)表达。在本研究中,我们专注于 S1P(1)和 VEGFR-2 之间的相互作用。我们表明 S1P 受体与 VEGFR-2 形成复合物,并且 S1P(1)/VEGFR-2 复合物与蛋白激酶 C(PKC)-alpha 和 ERK1/2 相关。此外,该复合物引发双向信号,因为 S1P 诱导的 ERK1/2 磷酸化对 VEGFR-2 激酶抑制敏感,而 VEGF-A 诱导的 ERK1/2 磷酸化对百日咳毒素处理以及 S1P(1)小干扰 RNA(siRNA)处理敏感。S1P 和 VEGF-A 诱导的趋化性对百日咳毒素处理和 S1P(1)siRNA 处理均敏感。VEGF-A 和 S1P(1)激动剂 SEW-2871 诱导的 ERK1/2 磷酸化均被 PKC-alpha 和 PKC-betaI siRNA 抑制。我们假设 VEGFR-2 与 S1P(1)形成信号复合物,引发双向信号,调节 ML-1 细胞中 ERK1/2 磷酸化和趋化性。

相似文献

1
S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration.S1P1 与 VEGFR-2 与细胞外调节激酶 1/2 和蛋白激酶 C-α形成信号复合物,调节 ML-1 甲状腺癌细胞迁移。
Endocrinology. 2010 Jul;151(7):2994-3005. doi: 10.1210/en.2009-1387. Epub 2010 May 25.
2
Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.1-磷酸鞘氨醇与ML-1滤泡状甲状腺癌细胞中血管内皮生长因子信号传导之间的相互作用。
Endocr Relat Cancer. 2008 Jun;15(2):521-34. doi: 10.1677/ERC-07-0253.
3
Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2.鞘氨醇激酶作为一种癌基因:自分泌的1-磷酸鞘氨醇通过一种依赖蛋白激酶C-α和ERK1/2的机制调节ML-1甲状腺癌细胞迁移。
Endocrinology. 2009 May;150(5):2055-63. doi: 10.1210/en.2008-0625. Epub 2008 Dec 30.
4
Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways.1-磷酸鞘氨醇诱导的Flk-1反式激活通过S1P1/S1P3依赖性β-抑制蛋白/c-Src途径刺激小鼠胚胎干细胞增殖。
Stem Cell Res. 2014 Jan;12(1):69-85. doi: 10.1016/j.scr.2013.08.013. Epub 2013 Sep 7.
5
Sphingosine 1-phosphate regulation of extracellular signal-regulated kinase-1/2 in embryonic stem cells.鞘氨醇 1-磷酸对胚胎干细胞细胞外信号调节激酶 1/2 的调节作用。
Stem Cells Dev. 2009 Nov;18(9):1319-30. doi: 10.1089/scd.2009.0023.
6
Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity.鞘氨醇-1-磷酸和血管内皮生长因子诱导的内皮细胞趋化性的差异调节。G(ialpha2)连接的Rho激酶活性的参与。
Am J Respir Cell Mol Biol. 2001 Jun;24(6):711-9. doi: 10.1165/ajrcmb.24.6.4323.
7
Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: upregulation in hypertension.鞘氨醇-1-磷酸诱导的炎症涉及血管细胞中的受体酪氨酸激酶转激活:高血压中的上调。
Hypertension. 2011 Apr;57(4):809-18. doi: 10.1161/HYPERTENSIONAHA.110.162719. Epub 2011 Mar 7.
8
Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis.红葡萄皮多酚对1-磷酸鞘氨醇和血管内皮生长因子诱导的内皮细胞趋化作用的抑制与早期血小板活化因子合成减少相关。
Free Radic Biol Med. 2006 Feb 15;40(4):581-90. doi: 10.1016/j.freeradbiomed.2005.09.015. Epub 2005 Oct 14.
9
HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion.高密度脂蛋白和神经鞘氨醇-1-磷酸通过 ERK1/2 和 S1P 受体激活前列腺癌细胞系 DU145 中的 stat3,促进细胞迁移和侵袭。
Prostate. 2011 May 15;71(7):690-9. doi: 10.1002/pros.21285. Epub 2010 Oct 26.
10
Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation.鞘氨醇-1-磷酸通过激活S1P1诱导T-ALL母细胞产生剂量依赖性趋化或负趋化作用。
PLoS One. 2016 Jan 29;11(1):e0148137. doi: 10.1371/journal.pone.0148137. eCollection 2016.

引用本文的文献

1
Stromal interaction molecule 1 (STIM1) knock down attenuates invasion and proliferation and enhances the expression of thyroid-specific proteins in human follicular thyroid cancer cells.基质相互作用分子 1(STIM1)敲低可抑制人甲状腺滤泡癌细胞的侵袭和增殖,并增强甲状腺特异性蛋白的表达。
Cell Mol Life Sci. 2021 Aug;78(15):5827-5846. doi: 10.1007/s00018-021-03880-0. Epub 2021 Jun 21.
2
S1PR1 and VEGFR2 - a synergy that promotes tumor angiogenesis?S1PR1与VEGFR2——一种促进肿瘤血管生成的协同作用?
Mol Cell Oncol. 2020 Apr 7;7(4):1746131. doi: 10.1080/23723556.2020.1746131. eCollection 2020.
3
Post-translational modifications of S1PR1 and endothelial barrier regulation.
S1PR1 的翻译后修饰与内皮屏障调节。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158760. doi: 10.1016/j.bbalip.2020.158760. Epub 2020 Jun 22.
4
Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling.鞘氨醇-1-磷酸受体 1 活性通过放大 VEGF-VEGFR2 血管生成信号促进肿瘤生长。
Cell Rep. 2019 Dec 10;29(11):3472-3487.e4. doi: 10.1016/j.celrep.2019.11.036.
5
O-cyclic phytosphingosine-1-phosphate stimulates HIF1α-dependent glycolytic reprogramming to enhance the therapeutic potential of mesenchymal stem cells.O-环植物鞘氨醇-1-磷酸刺激 HIF1α 依赖性糖酵解重编程,以增强间充质干细胞的治疗潜力。
Cell Death Dis. 2019 Aug 5;10(8):590. doi: 10.1038/s41419-019-1823-7.
6
S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.S1PR1 作为癌症治疗中一种新的有前途的治疗靶点。
Mol Diagn Ther. 2019 Aug;23(4):467-487. doi: 10.1007/s40291-019-00401-5.
7
Complex Formation between VEGFR2 and the β-Adrenoceptor.VEGFR2 与β-肾上腺素能受体的复合物形成。
Cell Chem Biol. 2019 Jun 20;26(6):830-841.e9. doi: 10.1016/j.chembiol.2019.02.014. Epub 2019 Apr 4.
8
Perfused 3D angiogenic sprouting in a high-throughput in vitro platform.高通量体外平台中灌注的 3D 血管生成发芽
Angiogenesis. 2019 Feb;22(1):157-165. doi: 10.1007/s10456-018-9647-0. Epub 2018 Aug 31.
9
Sphingosine 1-phosphate attenuates MMP2 and MMP9 in human anaplastic thyroid cancer C643 cells: Importance of S1P2.鞘氨醇 1-磷酸可减弱人未分化甲状腺癌细胞 C643 中的 MMP2 和 MMP9:S1P2 的重要性。
PLoS One. 2018 May 7;13(5):e0196992. doi: 10.1371/journal.pone.0196992. eCollection 2018.
10
Inhibition of PKCα reduces the ability of migration of kidney cancer cells but has no impact on cell apoptosis.抑制蛋白激酶Cα(PKCα)可降低肾癌细胞的迁移能力,但对细胞凋亡没有影响。
Exp Ther Med. 2017 May;13(5):2473-2479. doi: 10.3892/etm.2017.4258. Epub 2017 Mar 23.